- About |
- Contact Us |
- Site Map |
- Privacy Policy |
- Terms Of Use |
- Feedback
18. HIV/AIDS Prevention and Treatment
CUSTOM BOOKS
Select, organize, download, and save your choice of chapters into a single PDF file for printing and distribution. This is a free service.
My DCPP
Log in to view your saved custom books
CHAPTER INFO
Editors/Authors: Stefano Bertozzi, Nancy S. Padian, Jeny Wegbreit, Lisa M. DeMaria, Becca Feldman, Helene Gayle, Julian Gold, Robert Grant, and Michael T. Isbell
Pages: 40
Region
East Asia and Pacific
High Income OECD
Latin America and the Caribbean
South Asia
Sub-Saharan Africa
Disease / Condition
Adolescent & Childhood Diseases
Contraception
HIV/AIDS
Illicit Opiate Abuse
Infectious Diseases
Maternal & Neonatal Conditions
Maternal Conditions
Neonatal Conditions
Nutrition
Sexually Transmitted Infections
Women's Health
Abstract
Despite the alarming speed with which HIV/AIDS continues to spread around the world, several countries have achieved significant successes in curbing its transmission, including interventions that promote condom use, target populations that transmit the virus in both high– and low–risk groups, and focus on surveillance and control of sexually transmitted infections. However, the lack of sound evidence regarding the effectiveness of HIV interventions hinders policy makers' ability to tailor those interventions to the nature and stage of national epidemics.
Yet, evidence is mounting in support of certain interventions, including school–based sex education, peer education for sex workers, avoidance of unwanted pregnancies among infected mothers, use of antiretroviral therapy by infected mothers, needle–exchange programs for illegal drug users, and implementation of such blood safety practices as screening all donated blood. Countries with low–level epidemics should emphasize interventions that target individuals at especially high risk of being infected or transmitting the virus, whereas countries experiencing generalized epidemics should target entire populations.
While a number of promising new prevention interventions are in the pipeline, the assessment of most of these strategies is years away. In contrast, research on care and treatment has proven far more successful. For example, the ability of HIV to evolve resistance to antiretroviral drugs rapidly appears to assure continued investment in new drug development. The greatest challenge facing developing countries is to adapt care and treatment modalities in ways that help prolong high–quality life without overburdening a fragile health care infrastructure that must also address other pressing health concerns.
Sections
Click on the links below to read the full text.
Figures
Boxes
- 18.1 Successful HIV Prevention Strategies
- 18.2 Comprehensive Sex Education Versus Abstinence-Only Education
- 18.3 Preventing Mother-to-Child Transmission: Antiretroviral Therapy or Contraception?
- 18.4 Thailand's 100 Percent Condom Program
- 18.5 Uganda HIV/AIDS Prevention Program
- 18.6 Antiretroviral Drugs
- 18.7 Interventions in the Pipeline or in Trial
Tables
- 18.1 Deaths and Disability-Adjusted Life Years Attributed to AIDS by Region, Age, and Gender, 2001
- 18.2 Estimated HIV Transmission Risk per Exposure
- 18.3 Effectiveness of HIV Interventions
- 18.4 Cost-Effectiveness of Interventions by Epidemic Profile
- 18.5 Epidemic Profiles
- 18.6 Effect of Antiretroviral Therapy on Transmission Dynamics
- 18.7 Cost-Effectiveness of Care and Treatment for HIV/AIDS
